Nuveen Asset Management LLC Raises Stock Holdings in Plexus Corp. (NASDAQ:PLXS)

Nuveen Asset Management LLC boosted its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 6.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 351,557 shares of the technology company's stock after purchasing an additional 21,911 shares during the quarter. Nuveen Asset Management LLC owned about 1.30% of Plexus worth $55,012,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in PLXS. Pacer Advisors Inc. bought a new stake in Plexus during the 4th quarter valued at approximately $107,489,000. American Century Companies Inc. raised its stake in Plexus by 72.2% during the 4th quarter. American Century Companies Inc. now owns 544,017 shares of the technology company's stock valued at $85,128,000 after purchasing an additional 228,027 shares during the period. Fuller & Thaler Asset Management Inc. purchased a new stake in shares of Plexus during the 4th quarter worth approximately $24,747,000. JPMorgan Chase & Co. raised its holdings in shares of Plexus by 146.9% during the 4th quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company's stock worth $40,501,000 after acquiring an additional 154,003 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Plexus by 1,875.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 137,466 shares of the technology company's stock worth $21,511,000 after acquiring an additional 130,506 shares in the last quarter. Institutional investors own 94.45% of the company's stock.

Insider Buying and Selling at Plexus

In other news, CFO Patrick John Jermain sold 4,328 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $132.29, for a total transaction of $572,551.12. Following the transaction, the chief financial officer now owns 25,637 shares of the company's stock, valued at approximately $3,391,518.73. This represents a 14.44% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael J. Running sold 1,250 shares of the stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the transaction, the insider now directly owns 1,276 shares in the company, valued at $176,879.12. The trade was a 49.49% decrease in their position. The disclosure for this sale can be found here. 1.76% of the stock is currently owned by corporate insiders.

Plexus Trading Down 1.4%

PLXS traded down $1.91 during trading on Wednesday, reaching $130.26. The company had a trading volume of 115,370 shares, compared to its average volume of 168,733. The business has a 50 day simple moving average of $125.45 and a 200-day simple moving average of $142.76. The stock has a market cap of $3.53 billion, a P/E ratio of 30.22 and a beta of 0.80. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 52 week low of $100.96 and a 52 week high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.54 by $0.12. The company had revenue of $980.17 million for the quarter, compared to the consensus estimate of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. Plexus's quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.94 EPS. On average, equities analysts anticipate that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently issued reports on PLXS shares. Needham & Company LLC reaffirmed a "buy" rating and set a $162.00 price objective (down from $172.00) on shares of Plexus in a report on Friday, April 25th. Benchmark restated a "buy" rating and set a $160.00 price target on shares of Plexus in a report on Friday, May 16th. Finally, Stifel Nicolaus set a $145.00 price target on Plexus in a research report on Thursday, April 24th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $155.67.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.